Dr Reddy's Labs reports 9.5 percent fall in consolidated net profit after tax to Rs 1342 crore in Q2
Indian generic drugmaker Dr Reddy's Laboratories recorded a 9.5 percent decline in its consolidated net profit after tax to ...
Its draft red herring prospectus was filed on July 31. Rubicon, which competes with several listed entities like Sun Pharma, ...
Dr. Reddy's Laboratories Ltd. 500124 shares advanced 2.39% to 1,303.00 Indian rupees Wednesday, on what proved to be an ...
Apollo Hospitals on Wednesday reported a 59 percent rise in its consolidated net profit at Rs 395.70 crore in September 2024 quarter. It had reported a net profit of Rs 248.80 crore during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback